{
    "Trade/Device Name(s)": [
        "ADVIA Centaur Toxoplasma IgG (Toxo G) Assay"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K102681",
    "Predicate Device Reference 510(k) Number(s)": [
        "K012183"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LGD"
    ],
    "Summary Letter Date": "April 13, 2011",
    "Summary Letter Received Date": "April 14, 2011",
    "Submission Date": "June 11, 2010",
    "Regulation Number(s)": [
        "21 CFR 866.3780"
    ],
    "Regulation Name(s)": [
        "Toxoplasma gondii Serological Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "immunology"
    ],
    "Analyte(s)": [
        "Toxoplasma gondii IgG antibody"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparinized Plasma",
        "EDTA Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur systems"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme Linked Immunoabsorbent Assay (ELISA)",
        "Microparticle direct in vitro diagnostic immunoassay"
    ],
    "Methodologies": [
        "Antibody capture immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur Toxoplasma IgG (Toxo G) Assay, an ELISA for detection of IgG antibodies to Toxoplasma gondii in serum or plasma.",
    "Indications for Use Summary": "Intended for quantitative and qualitative detection of IgG antibodies to Toxoplasma gondii in human serum or plasma, aiding in assessment of immunological response, including in women of childbearing age; may be used with IgM result to determine recent serological response.",
    "fda_folder": "Microbiology"
}